Oleclumab
Oleclumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Oleclumab is under investigation in clinical trial NCT03819465 (A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC).
| Trade Name | Oleclumab |
| Generic | Oleclumab |
| Oleclumab Other Names | Oleclumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Oleclumab
